AstraZeneca Slides on $6.9 Billion Cancer Drug Deal with Japan's Daiichi Sankyo
AstraZeneca shares traded near the bottom of the London market Friday after the drugmaker agreed a potential $6.9 billion deal with Japan's Daiichi Sankyo Co. to develop and market a breast and gastric cancer treatment over the coming years.
...
https://www.thestreet.com/investing/stoc...yptr=yahoo
Astra heute 6% runter...
AstraZeneca shares traded near the bottom of the London market Friday after the drugmaker agreed a potential $6.9 billion deal with Japan's Daiichi Sankyo Co. to develop and market a breast and gastric cancer treatment over the coming years.
...
https://www.thestreet.com/investing/stoc...yptr=yahoo
Astra heute 6% runter...
![[Bild: AZNc1dl1711.png]](https://finviz.com/publish/032919/AZNc1dl1711.png)
__________________